West Pharmaceutical Services Revenue increased by 5.0% to $844.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.0%, from $698.00M to $844.90M. Over 4 years (FY 2021 to FY 2025), Revenue shows relatively stable performance with a 2.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $723.60M | $706.50M | $730.80M | $720.00M | $771.30M | $686.90M | $708.70M | $716.60M | $753.80M | $747.40M | $732.00M | $695.40M | $702.10M | $746.90M | $748.80M | $698.00M | $766.50M | $804.60M | $805.00M | $844.90M |
| QoQ Change | — | -2.4% | +3.4% | -1.5% | +7.1% | -10.9% | +3.2% | +1.1% | +5.2% | -0.8% | -2.1% | -5.0% | +1.0% | +6.4% | +0.3% | -6.8% | +9.8% | +5.0% | +0.0% | +5.0% |
| YoY Change | — | — | — | — | +6.6% | -2.8% | -3.0% | -0.5% | -2.3% | +8.8% | +3.3% | -3.0% | -6.9% | -0.1% | +2.3% | +0.4% | +9.2% | +7.7% | +7.5% | +21.0% |